why choose us

First received: November 23, 2022

Clinical Trial: Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Spinal Cord Injuries

Study Type: INTERVENTIONAL


Official Title: Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Brief Summary: Spinal cord injury (SCI) is associated with severe neuropathic pain that is often refractory to pharmacological intervention.Preliminary data suggest brivaracetam is a mechanism-based pharmacological intervention for neuropathic pain in SCI.Based on this and other reports in the literature, SCI-related neuropathic pain is hypothesized to occur largely because of upregulation of synaptic vesicle protein 2A (SV2A) within the substantia gelatinosa of the injured spinal cord.Furthermore, compared to placebo,…

Read more